Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$9K Sell
22,000
-3,200
-13% -$430K 0.01% 189
2017
Q2
$40K Sell
25,200
-37,500
-60% -$5.06M 0.07% 121
2017
Q1
$134K Buy
62,700
+53,700
+597% +$6.96M 0.18% 98
2016
Q4
$6K Sell
9,000
-57,600
-86% -$6.79M 0.01% 216
2016
Q3
$21K Sell
66,600
-73,700
-53% -$9.65M 0.02% 268
2016
Q2
$515K Buy
140,300
+105,400
+302% +$13.7M 0.44% 46
2016
Q1
$7K Buy
+34,900
New +$4.44M 0.01% 255

Other funds holding CLX

FT Options's CLX Position: Q3 2017 in Review

FT Options reduced its Clorox (CLX) stake by 75% in Q3 2017, selling an estimated $971K and leaving 2,400 shares worth $317K. The position accounts for 0.48% of the portfolio, ranked #53.

FT Options first reported a position in CLX in Q4 2016 and has held it in 3 quarters since. The position peaked at $1.28M in Q2 2017. 857 funds tracked by Wall St. Rank hold CLX as of Q3 2017.

  • FT Options held 2,400 shares of Clorox worth $317K as of Q3 2017.
  • FT Options sold 7,223 Clorox shares in Q3 2017, an estimated $971K.
  • Clorox made up 0.48% of FT Options's portfolio in Q3 2017, its #53 holding.
  • FT Options first reported a position in Clorox in Q4 2016 and has held it in 3 quarters since.
  • FT Options's Clorox position peaked at $1.28M in Q2 2017.
  • 857 funds tracked by Wall St. Rank held Clorox as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.